Terms: = Colorectal cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Prognosis
63 results:
1. Impacts of some clinicopathodemography and colorectal tissues key cell cycle and mucin stabilizing molecules on the metastasis trend in colorectal cancer patients.
Ghorbani Ranjbary A; Mehrzad J; Rahbar N; Dehghani H
Mol Biol Rep; 2023 Oct; 50(10):8589-8601. PubMed ID: 37644368
[TBL] [Abstract] [Full Text] [Related]
2. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in colorectal cancer and Invasive Breast cancer.
Cao Y; Efetov SK; He M; Fu Y; Beeraka NM; Zhang J; Zhang X; Bannimath N; Chen K
Arch Immunol Ther Exp (Warsz); 2023 Aug; 71(1):19. PubMed ID: 37566162
[TBL] [Abstract] [Full Text] [Related]
3. Electrochemical biotool for the dual determination of epithelial mucins associated to prognosis and minimal residual disease in colorectal cancer.
Tejerina-Miranda S; Blázquez-García M; Serafín V; Montero-Calle A; Garranzo-Asensio M; Reviejo AJ; Pedrero M; Pingarrón JM; Barderas R; Campuzano S
Int J Biol Macromol; 2023 Sep; 248():125996. PubMed ID: 37499706
[TBL] [Abstract] [Full Text] [Related]
4. Immunophenotypic profiles and prognosis for colorectal mucinous adenocarcinomas are dependent on anatomic location.
Patel C; Behring M; Al Diffalha S; Dhall D; Lee G; Shanmugam C; Grizzle WE; Manne U
Cancer Med; 2023 Apr; 12(8):9637-9643. PubMed ID: 36916704
[TBL] [Abstract] [Full Text] [Related]
5. The role of immunotherapy in advanced and recurrent MMR deficient and proficient endometrial carcinoma.
Di Dio C; Bogani G; Di Donato V; Cuccu I; Muzii L; Musacchio L; Scambia G; Lorusso D
Gynecol Oncol; 2023 Feb; 169():27-33. PubMed ID: 36493574
[TBL] [Abstract] [Full Text] [Related]
6. MSI testing : What's new? What should be considered?
Rüschoff J; Baretton G; Bläker H; Dietmaier W; Dietel M; Hartmann A; Horn LC; Jöhrens K; Kirchner T; Knüchel R; Mayr D; Merkelbach-Bruse S; Schildhaus HU; Schirmacher P; Tiemann M; Tiemann K; Weichert W; Büttner R
Pathologe; 2021 Nov; 42(Suppl 1):110-118. PubMed ID: 34477921
[TBL] [Abstract] [Full Text] [Related]
7. [MSI testing : What is new? What should be considered? German version].
Rüschoff J; Baretton G; Bläker H; Dietmaier W; Dietel M; Hartmann A; Horn LC; Jöhrens K; Kirchner T; Knüchel R; Mayr D; Merkelbach-Bruse S; Schildhaus HU; Schirmacher P; Tiemann M; Tiemann K; Weichert W; Büttner R
Pathologe; 2021 Jul; 42(4):414-423. PubMed ID: 34043067
[TBL] [Abstract] [Full Text] [Related]
8. colorectal cancer with invasive micropapillary components (IMPCs) shows high lymph node metastasis and a poor prognosis: A retrospective clinical study.
Guo Z; Yang Z; Li D; Tang J; Xu J; Shen H; Yuan Y
Medicine (Baltimore); 2020 May; 99(21):e20238. PubMed ID: 32481300
[TBL] [Abstract] [Full Text] [Related]
9. Pathological complete response may underestimate distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery: Incidence, metastatic pattern, and risk factors.
Sun Y; Wu X; Zhang Y; Lin H; Lu X; Huang Y; Chi P
Eur J Surg Oncol; 2019 Jul; 45(7):1225-1231. PubMed ID: 30879932
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic and clinicopathological value of muc1 expression in colorectal cancer: A meta-analysis.
Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L
Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic significance of circulating tumor cells (CTCs) in Egyptian non-metastatic colorectal cancer patients: A comparative study for four different techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorphology).
Bahnassy AA; Salem SE; Mohanad M; Abulezz NZ; Abdellateif MS; Hussein M; Zekri CAN; Zekri AN; Allahloubi NMA
Exp Mol Pathol; 2019 Feb; 106():90-101. PubMed ID: 30578762
[TBL] [Abstract] [Full Text] [Related]
12. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated muc1 via PI3K/AKT pathway.
Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
[TBL] [Abstract] [Full Text] [Related]
13. Differential expression of mucin 1 and mucin 2 in colorectal cancer.
Kasprzak A; Siodła E; Andrzejewska M; Szmeja J; Seraszek-Jaros A; Cofta S; Szaflarski W
World J Gastroenterol; 2018 Sep; 24(36):4164-4177. PubMed ID: 30271081
[TBL] [Abstract] [Full Text] [Related]
14. muc1 expression in colorectal carcinoma: Clinicopathological correlation and prognostic significance.
Díaz Del Arco C; Garré P; Molina Roldán E; Lorca V; Cerón Nieto MÁ; Fernández Aceñero MJ
Rev Esp Patol; 2018; 51(4):204-209. PubMed ID: 30269770
[TBL] [Abstract] [Full Text] [Related]
15. Mucinous intrahepatic cholangiocarcinoma: a distinct variant.
Chi Z; Bhalla A; Saeed O; Cheng L; Curless K; Wang HL; Patil DT; Lin J
Hum Pathol; 2018 Aug; 78():131-137. PubMed ID: 29698701
[TBL] [Abstract] [Full Text] [Related]
16. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes muc1/p53/miR-200c-dependent epithelial identity.
Ye J; Wei X; Shang Y; Pan Q; Yang M; Tian Y; He Y; Peng Z; Chen L; Chen W; Wang R
Oncogene; 2017 Nov; 36(46):6391-6407. PubMed ID: 28745318
[TBL] [Abstract] [Full Text] [Related]
17. The aspirin metabolite salicylate inhibits lysine acetyltransferases and muc1 induced epithelial to mesenchymal transition.
Fernandez HR; Lindén SK
Sci Rep; 2017 Jul; 7(1):5626. PubMed ID: 28717171
[TBL] [Abstract] [Full Text] [Related]
18. Histochemical and immunohistochemical study of mucinous rectal carcinoma.
Lungulescu CV; Răileanu S; Afrem G; Ungureanu BS; Florescu DN; Gheonea IA; Șovăilă S; Crăițoiu Ș
J Med Life; 2017; 10(2):139-143. PubMed ID: 28616090
[TBL] [Abstract] [Full Text] [Related]
19. Modulation of macrophage polarization and lung cancer cell stemness by muc1 and development of a related small-molecule inhibitor pterostilbene.
Huang WC; Chan ML; Chen MJ; Tsai TH; Chen YJ
Oncotarget; 2016 Jun; 7(26):39363-39375. PubMed ID: 27276704
[TBL] [Abstract] [Full Text] [Related]
20. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
[TBL] [Abstract] [Full Text] [Related]
[Next]
